It is a cell-permeable, selective NNMT inhibitor that does not require cofactors for activity
Dosage, Concentration, Route of Administration Dosage : Seek advice from a licensed physician, medical director, or other healthcare provider Concentration : 50,000 IU/ml Route of Administration : For IM Injection only Resources: Tutorial: How to Open Your Medication Vial Not sure how to administer this medication
Korecka A, Dona A, Lahiri S, et al
Our team looks at your health, goals, and lifestyle to recommend the right peptide therapy for you, whether thats semaglutide, tirzepatide, or another option
doi: 10.1080/21641846.2022.2124775 Summary Keywords myalgic encephalomyelitis/chronic fatigue syndrome, pathology, treatment, pathophysiology, diagnostic criteria Citation Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR and Pretorius E (2024) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Derivatization with fatty acids in peptide and protein drug discovery